HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
Gross Profit
HUTCHMED (China) Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HUTCHMED (China) Ltd
LSE:HCM
|
Gross Profit
$453.6m
|
CAGR 3-Years
126%
|
CAGR 5-Years
45%
|
CAGR 10-Years
34%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Gross Profit
HK$6.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Gross Profit
¥6.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Gross Profit
¥21.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Gross Profit
¥9.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Gross Profit
HK$38.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Gross Profit?
Gross Profit
453.6m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Gross Profit amounts to 453.6m USD.
What is HUTCHMED (China) Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
34%
Over the last year, the Gross Profit growth was 293%. The average annual Gross Profit growth rates for HUTCHMED (China) Ltd have been 126% over the past three years , 45% over the past five years , and 34% over the past ten years .